Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study.

Thorax·2026
Same author

Life Expectancy in Chronic Obstructive Pulmonary Disease.

JAMA internal medicine·2026
Same author

Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection.

PloS one·2026
Same author

Discriminative Performance and Clinical utility of COPD Exacerbation Categories for Predicting Future Exacerbations.

American journal of respiratory and critical care medicine·2026
Same author

A general sample size framework for developing or updating a predictive algorithm: with application to clinical prediction models.

BMC medical research methodology·2026
Same author

Expected Value of Sample Information Calculations for Risk Prediction Model Development.

Statistics in medicine·2026
Same journal

Beyond the Trials: Real-World Insights into Tezepelumab Efficacy.

American journal of respiratory and critical care medicine·2026
Same journal

Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLC.

American journal of respiratory and critical care medicine·2026
Same journal

Beyond Frequency: Rethinking Exacerbation Risk in COPD.

American journal of respiratory and critical care medicine·2026
Same journal

Inhaled Triple Therapy in Symptomatic Smokers with Preserved FEV1/FVC ratio: The CHRONOS Clinical Trial.

American journal of respiratory and critical care medicine·2026
Same journal

Occupational Exposure to Dust and Fumes Increases Risk for Future Adverse Clinical Outcomes.

American journal of respiratory and critical care medicine·2026
Same journal

Acquired Willebrand syndrome during continuous or pulsatile extracorporeal carbon dioxide removal.

American journal of respiratory and critical care medicine·2026
See all related articles
  1. Home
  2. Reply To Liu Et Al.: Beyond Frequency: Rethinking Exacerbation Risk In Copd
  1. Home
  2. Reply To Liu Et Al.: Beyond Frequency: Rethinking Exacerbation Risk In Copd

Related Experiment Video

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Reply to Liu et al.: Beyond Frequency: Rethinking Exacerbation Risk in COPD

Surya P Bhatt1,2, Mohsen Sadatsafavi3,

  • 1Center for Lung Analytics and Imaging Research, University of Alabama at Birmingham, Birmingham, AL, USA.

American Journal of Respiratory and Critical Care Medicine
|June 27, 2026
Summary

No abstract available in PubMed .

Keywords:
Chronic obstructive pulmonary diseaseExacerbationsNet BenefitPrediction

Related Experiment Videos

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024